Alzheimer’s Disease Research Unit

Alzheimer’s disease (AD) is the most common type of dementia worldwide.

The incidence and prevalence of AD increases with age. It is estimated that more people will be affected by this condition, due to the increasing longevity of our population.

The Alzheimer and Cognitive Disorders Clinic, a division of the McGill Centre for Studies in Aging, was founded in 1997 to establish a clinic that specializes in AD and related disorders.

The Clinic’s primary focus is to seek improved therapies, both symptomatic and preventive, for AD and cognitive disorders; to ensure long-term stabilization for patients; and to enhance the quality of life for patients and caregivers.

The Clinic offers an expertise in the early diagnosis and management of AD and cognitive disorders, including vascular dementia and mild cognitive impairment.

Evaluation, treatment and follow-up are available, as well as referral to other resources, such as help and support services, if desired.

The Clinic is actively involved in cognitive research and is recognized internationally as a clinical trial site. Clinical trials (Phases II-IV) that test the efficacy and safety of experimental drugs for AD and other cognitive disorders are ongoing.

Dr. Serge Gauthier, MD, FRCPC, CM, neurologist, and specialist in the field, leads a team of experienced and dedicated health professionals. Evaluations are carried out in a friendly and inviting atmosphere at a location which is easily accessible.

Further Information

For an appointment with the following doctors:

Dr. Serge Gauthier, C.M., C.Q., MD, FRCPC, CM

Dr. Pedro Rosa-Neto, MD, PhD

Dr. Paolo Vitali, MD, PhD, FRCPC

Please send your consultation request by fax , email or mail to the following address:
McGill University Research Centre for Studies in Aging
6825 LaSalle Boulevard
Verdun (QC) H4H 1R3